Shares of Cardlytics Inc (NASDAQ:CDLX) have earned a consensus rating of “Buy” from the nine brokerages that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $46.50.
A number of analysts have recently commented on CDLX shares. JPMorgan Chase & Co. cut Cardlytics from an “overweight” rating to a “neutral” rating and set a $58.00 price target for the company. in a research note on Thursday, November 14th. They noted that the move was a valuation call. Zacks Investment Research cut Cardlytics from a “buy” rating to a “hold” rating in a research report on Thursday. Craig Hallum assumed coverage on shares of Cardlytics in a research note on Monday. They set a “buy” rating and a $75.00 price target for the company. Raymond James lifted their price objective on shares of Cardlytics from $40.00 to $53.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Finally, ValuEngine lowered shares of Cardlytics from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd.
In related news, CEO Scott D. Grimes sold 250,000 shares of Cardlytics stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $32.30, for a total transaction of $8,075,000.00. Also, Director Mark A. Johnson sold 100,000 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $32.30, for a total value of $3,230,000.00. Over the last ninety days, insiders bought 316,475 shares of company stock worth $11,914,849 and sold 963,561 shares worth $40,132,784. 21.90% of the stock is currently owned by corporate insiders.
Shares of CDLX traded down $2.35 on Tuesday, reaching $61.35. 472,897 shares of the company’s stock were exchanged, compared to its average volume of 352,988. The stock has a market capitalization of $1.45 billion, a P/E ratio of -28.67 and a beta of 1.71. The business has a 50 day moving average price of $47.81 and a two-hundred day moving average price of $34.42. Cardlytics has a 12 month low of $9.80 and a 12 month high of $65.43.
Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.31. Cardlytics had a negative net margin of 17.01% and a negative return on equity of 44.53%. The firm had revenue of $56.42 million for the quarter, compared to analysts’ expectations of $50.02 million. During the same period last year, the firm earned ($0.15) earnings per share. The business’s revenue for the quarter was up 63.2% on a year-over-year basis. As a group, equities analysts forecast that Cardlytics will post -1.01 EPS for the current fiscal year.
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.
Featured Article: Consumer behavior in bull markets
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.